TreeWAS – Variant ID: rs7920721

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C34 Malignant neoplasm of bronchus and lung	0.198	0.802	0.000
C34.3 Lower lobe, bronchus or lung	0.196	0.804	0.000
C34.0 Main bronchus	0.191	0.809	0.000
C34.2 Middle lobe, bronchus or lung	0.172	0.828	0.000
C34.1 Upper lobe, bronchus or lung	0.168	0.832	0.000
C34.8 Overlapping lesion of bronchus and lung	0.167	0.833	0.000
C34.9 Bronchus or lung, unspecified	0.166	0.834	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.037	0.963	0.000
B34.9 Viral infection, unspecified	0.000	0.966	0.034
C38 Malignant neoplasm of heart, mediastinum and pleura	0.030	0.970	0.000
T81.3 Disruption of operation wound, not elsewhere classified	0.000	0.972	0.028
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.027	0.973	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.025	0.974	0.000
C31 Malignant neoplasm of accessory sinuses	0.025	0.975	0.000
C33 Malignant neoplasm of trachea	0.025	0.975	0.000
C38.3 Mediastinum, part unspecified	0.024	0.976	0.000
C37 Malignant neoplasm of thymus	0.022	0.977	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.023	0.977	0.000
C38.4 Pleura	0.022	0.978	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.021	0.978	0.000
C38.2 Posterior mediastinum	0.021	0.978	0.000
C38.1 Anterior mediastinum	0.021	0.978	0.000
C38.0 Heart	0.021	0.978	0.000
C39.9 Ill-defined sites within the respiratory system	0.019	0.981	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.019	0.981	0.000
C39.0 Upper respiratory tract, part unspecified	0.019	0.981	0.000
C30.1 Middle ear	0.018	0.981	0.000
C31.9 Accessory sinus, unspecified	0.018	0.982	0.000
C31.8 Overlapping lesion of accessory sinuses	0.018	0.982	0.000
C31.3 Sphenoidal sinus	0.018	0.982	0.000
C31.2 Frontal sinus	0.018	0.982	0.000
C31.1 Ethmoidal sinus	0.018	0.982	0.000
C30.0 Nasal cavity	0.017	0.982	0.000
C31.0 Maxillary sinus	0.017	0.983	0.000
T78.4 Allergy, unspecified	0.000	0.984	0.016
C32 Malignant neoplasm of larynx	0.014	0.986	0.000
B34 Viral infection of unspecified site	0.000	0.986	0.014
B34.4 Papovirus infection, unspecified	0.000	0.989	0.011
C32.8 Overlapping lesion of larynx	0.010	0.989	0.000
C32.3 Laryngeal cartilage	0.010	0.989	0.000
C32.2 Subglottis	0.010	0.989	0.000
B34.3 Parvovirus infection, unspecified	0.000	0.990	0.010
B34.2 Coronavirus infection, unspecified	0.000	0.990	0.010
B34.1 Enterovirus infection, unspecified	0.000	0.990	0.010
B34.0 Adenovirus infection, unspecified	0.000	0.990	0.010
C32.1 Supraglottis	0.009	0.991	0.000
D22.2 Melanocytic naevi of ear and external auricular canal	0.009	0.991	0.000
C32.0 Glottis	0.008	0.992	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.008	0.992	0.000
C32.9 Larynx, unspecified	0.006	0.993	0.000
N87.1 Moderate cervical dysplasia	0.007	0.993	0.000
T78 Adverse effects, not elsewhere classified	0.000	0.994	0.006
B25-B34 Other viral diseases	0.000	0.994	0.005
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.995	0.005
B34.8 Other viral infections of unspecified site	0.001	0.995	0.005
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.995	0.005
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.995	0.005
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.995	0.005
B27 Infectious mononucleosis	0.000	0.995	0.005
R17 Unspecified jaundice	0.005	0.995	0.000
G47.1 Disorders of excessive somnolence [hypersomnias]	0.004	0.996	0.000
T78.9 Adverse effect, unspecified	0.000	0.996	0.004
B33 Other viral diseases, not elsewhere classified	0.000	0.996	0.004
G45.4 Transient global amnesia	0.004	0.996	0.000
B30 Viral conjunctivitis	0.000	0.996	0.004
B26 Mumps	0.000	0.996	0.004
B27.9 Infectious mononucleosis, unspecified	0.000	0.996	0.004
T78.2 Anaphylactic shock, unspecified	0.000	0.996	0.004
T78.8 Other adverse effects, not elsewhere classified	0.000	0.996	0.004
T31.0 Burns involving less than 10% of body surface	0.004	0.996	0.000
D13.1 Stomach	0.000	0.996	0.004
B27.8 Other infectious mononucleosis	0.000	0.996	0.003
B27.1 Cytomegaloviral mononucleosis	0.000	0.996	0.003
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.996	0.004
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.996	0.004
B27.0 Gammaherpesviral mononucleosis	0.000	0.996	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
B33.2 Viral carditis	0.000	0.997	0.003
D63.0 Anaemia in neoplastic disease	0.000	0.997	0.003
B33.8 Other specified viral diseases	0.000	0.997	0.003
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.000	0.997	0.003
B33.3 Retrovirus infections, not elsewhere classified	0.000	0.997	0.003
B33.1 Ross River disease	0.000	0.997	0.003
B33.0 Epidemic myalgia	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
N87 Dysplasia of cervix uteri	0.003	0.997	0.000
B26.9 Mumps without complication	0.000	0.997	0.003
B26.8 Mumps with other complications	0.000	0.997	0.003
B26.3 Mumps pancreatitis	0.000	0.997	0.003
B26.2 Mumps encephalitis	0.000	0.997	0.003
B26.1 Mumps meningitis	0.000	0.997	0.003
B26.0 Mumps orchitis	0.000	0.997	0.003
B30.9 Viral conjunctivitis, unspecified	0.000	0.997	0.003
B30.8 Other viral conjunctivitis	0.000	0.997	0.003
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.000	0.997	0.003
B30.2 Viral pharyngoconjunctivitis	0.000	0.997	0.003
B30.1 Conjunctivitis due to adenovirus	0.000	0.997	0.003
B30.0 Keratoconjunctivitis due to adenovirus	0.000	0.997	0.003
N87.9 Dysplasia of cervix uteri, unspecified	0.003	0.997	0.000
C45.0 Mesothelioma of pleura	0.000	0.997	0.003
B25 Cytomegaloviral disease	0.000	0.997	0.003
D13.6 Pancreas	0.000	0.997	0.003
T39.0 Salicylates	0.000	0.997	0.003
S32.50 Fracture of pubis (closed)	0.003	0.997	0.000
C45.9 Mesothelioma, unspecified	0.000	0.997	0.003
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.000	0.997	0.003
G55.3 Nerve root and plexus compressions in other dorsopathies	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
O34 Maternal care for known or suspected abnormality of pelvic organs	0.000	0.997	0.003
O34.1 Maternal care for tumour of corpus uteri	0.000	0.997	0.003
C45 Mesothelioma	0.000	0.997	0.003
F60.9 Personality disorder, unspecified	0.000	0.997	0.003
G90.3 Multisystem degeneration	0.003	0.997	0.000
D13.7 Endocrine pancreas	0.000	0.997	0.003
O34.8 Maternal care for other abnormalities of pelvic organs	0.000	0.997	0.003
O34.0 Maternal care for congenital malformation of uterus	0.000	0.997	0.003
M43.02 Spondylolysis (Cervical region)	0.003	0.997	0.000
T81.1 Shock during or resulting from a procedure, not elsewhere classified	0.000	0.997	0.003
I21.2 Acute transmural myocardial infarction of other sites	0.003	0.997	0.000
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
R86.0 Abnormal level of enzymes	0.003	0.997	0.000
D23.5 Skin of trunk	0.000	0.997	0.003
B25.2 Cytomegaloviral pancreatitis	0.000	0.997	0.002
B25.1 Cytomegaloviral hepatitis	0.000	0.997	0.002
B25.0 Cytomegaloviral pneumonitis	0.000	0.997	0.002
D37.6 Liver, gallbladder and bile ducts	0.000	0.997	0.003
J94.8 Other specified pleural conditions	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
O34.7 Maternal care for abnormality of vulva and perineum	0.000	0.997	0.003
H20.0 Acute and subacute iridocyclitis	0.003	0.997	0.000
H21.0 Hyphaema	0.003	0.997	0.000
L29.9 Pruritus, unspecified	0.003	0.997	0.000
T31 Burns classified according to extent of body surface involved	0.003	0.997	0.000
D13.9 Ill-defined sites within the digestive system	0.000	0.997	0.002
N87.2 Severe cervical dysplasia, not elsewhere classified	0.002	0.997	0.000
R86.8 Other abnormal findings	0.002	0.997	0.000
C45.7 Mesothelioma of other sites	0.000	0.997	0.002
G90 Disorders of autonomic nervous system	0.003	0.997	0.000
D10.3 Other and unspecified parts of mouth	0.002	0.998	0.000
D13.3 Other and unspecified parts of small intestine	0.000	0.998	0.002
H15.8 Other disorders of sclera	0.002	0.998	0.000
D13.5 Extrahepatic bile ducts	0.000	0.998	0.002
D13.2 Duodenum	0.000	0.998	0.002
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.000	0.998	0.002
O34.6 Maternal care for abnormality of vagina	0.000	0.998	0.002
O34.5 Maternal care for other abnormalities of gravid uterus	0.000	0.998	0.002
T78.3 Angioneurotic oedema	0.000	0.998	0.002
G90.9 Disorder of autonomic nervous system, unspecified	0.002	0.998	0.000
D13.0 Oesophagus	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
C45.2 Mesothelioma of pericardium	0.000	0.998	0.002
C45.1 Mesothelioma of peritoneum	0.000	0.998	0.002
E87.3 Alkalosis	0.000	0.998	0.002
G90.0 Idiopathic peripheral autonomic neuropathy	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
Z43.2 Attention to ileostomy	0.000	0.998	0.002
H72 Perforation of tympanic membrane	0.000	0.998	0.002
D13.4 Liver	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Z71.3 Dietary counselling and surveillance	0.000	0.998	0.002
T31.1 Burns involving 10-19% of body surface	0.002	0.998	0.000
H15 Disorders of sclera	0.002	0.998	0.000
B25.8 Other cytomegaloviral diseases	0.000	0.998	0.002
G90.8 Other disorders of autonomic nervous system	0.002	0.998	0.000
G90.2 Horner's syndrome	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
M54.96 Dorsalgia, unspecified (Lumbar region)	0.000	0.998	0.002
D12.9 Anus and anal canal	0.000	0.998	0.002
H21.9 Disorder of iris and ciliary body, unspecified	0.002	0.998	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.002	0.998	0.000
O34.3 Maternal care for cervical incompetence	0.000	0.998	0.002
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.998	0.002
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.998	0.002
R86 Abnormal findings in specimens from male genital organs	0.002	0.998	0.000
F60.7 Dependent personality disorder	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
F60 Specific personality disorders	0.000	0.998	0.002
H20 Iridocyclitis	0.002	0.998	0.000
E14.9 Without complications	0.000	0.998	0.002
H16.1 Other superficial keratitis without conjunctivitis	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
H16 Keratitis	0.002	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
N26 Unspecified contracted kidney	0.000	0.998	0.002
N87.0 Mild cervical dysplasia	0.002	0.998	0.000
H16.0 Corneal ulcer	0.002	0.998	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.002	0.998	0.000
T31.9 Burns involving 90% or more of body surface	0.002	0.998	0.000
T31.8 Burns involving 80-89% of body surface	0.002	0.998	0.000
T31.7 Burns involving 70-79% of body surface	0.002	0.998	0.000
T31.6 Burns involving 60-69% of body surface	0.002	0.998	0.000
T31.5 Burns involving 50-59% of body surface	0.002	0.998	0.000
T31.4 Burns involving 40-49% of body surface	0.002	0.998	0.000
T31.3 Burns involving 30-39% of body surface	0.002	0.998	0.000
T31.2 Burns involving 20-29% of body surface	0.002	0.998	0.000
Z04.9 Examination and observation for unspecified reason	0.002	0.998	0.000
Z52.8 Donor of other organs and tissues	0.002	0.998	0.000
O34.4 Maternal care for other abnormalities of cervix	0.000	0.998	0.002
T02.40 Fractures involving multiple regions of both upper limbs (closed)	0.000	0.998	0.002
E14.4 With neurological complications	0.000	0.998	0.002
Z03.1 Observation for suspected malignant neoplasm	0.000	0.998	0.002
B25.9 Cytomegaloviral disease, unspecified	0.000	0.998	0.002
G90.4 Autonomic dysreflexia	0.002	0.998	0.000
G90.1 Familial dysautonomia [Riley-Day]	0.002	0.998	0.000
H20.9 Iridocyclitis, unspecified	0.002	0.998	0.000
R86.6 Abnormal cytological findings	0.002	0.998	0.000
T66-T78 Other and unspecified effects of external causes	0.000	0.998	0.002
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.002	0.998	0.000
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
H72.1 Attic perforation of tympanic membrane	0.000	0.998	0.002
R23.2 Flushing	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
B00.9 Herpesviral infection, unspecified	0.002	0.998	0.000
F41.9 Anxiety disorder, unspecified	0.002	0.998	0.000
H15.1 Episcleritis	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
H21.1 Other vascular disorders of iris and ciliary body	0.002	0.998	0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T40.5 Cocaine	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
F81.9 Developmental disorder of scholastic skills, unspecified	0.002	0.998	0.000
H15.0 Scleritis	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.000	0.998	0.002
M47.89 Other spondylosis (Site unspecified)	0.002	0.998	0.000
H21.4 Pupillary membranes	0.002	0.998	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.002	0.998	0.000
M23.8 Other internal derangements of knee	0.002	0.998	0.000
W07.0 Home	0.000	0.998	0.002
E14.6 With other specified complications	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
T71 Asphyxiation	0.000	0.998	0.002
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.000	0.998	0.002
H16.9 Keratitis, unspecified	0.002	0.998	0.000
H16.4 Corneal neovascularisation	0.002	0.998	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.998	0.002
R86.9 Unspecified abnormal finding	0.002	0.998	0.000
H15.9 Disorder of sclera, unspecified	0.002	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.000	0.998	0.002
H81.1 Benign paroxysmal vertigo	0.002	0.998	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.000	0.998	0.002
R86.5 Abnormal microbiological findings	0.002	0.998	0.000
R86.4 Abnormal immunological findings	0.002	0.998	0.000
R86.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R86.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R86.1 Abnormal level of hormones	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
F60.2 Dissocial personality disorder	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure	0.000	0.998	0.002
W21.9 Unspecified place	0.002	0.998	0.000
T75 Effects of other external causes	0.000	0.998	0.002
F60.4 Histrionic personality disorder	0.000	0.998	0.002
F60.1 Schizoid personality disorder	0.000	0.998	0.002
H16.3 Interstitial and deep keratitis	0.002	0.998	0.000
E14.2 Withrenal complications	0.000	0.998	0.002
H20.2 Lens-induced iridocyclitis	0.002	0.998	0.000
H21.2 Degeneration of iris and ciliary body	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.000	0.998	0.002
E14.1 With ketoacidosis	0.000	0.998	0.002
F60.5 Anankastic personality disorder	0.000	0.998	0.002
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.998	0.002
F60.6 Anxious [avoidant] personality disorder	0.000	0.998	0.002
H20.8 Other iridocyclitis	0.002	0.998	0.000
T40.1 Heroin	0.000	0.998	0.002
F60.8 Other specific personality disorders	0.000	0.998	0.002
J94.2 Haemothorax	0.002	0.998	0.000
G44.8 Other specified headache syndromes	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
T74 Maltreatment syndromes	0.000	0.998	0.002
T73 Effects of other deprivation	0.000	0.998	0.002
T69 Other effects of reduced temperature	0.000	0.998	0.002
T67 Effects of heat and light	0.000	0.998	0.002
M22.2 Patellofemoral disorders	0.000	0.998	0.002
D37.7 Other digestive organs	0.000	0.998	0.002
E14.5 With peripheral circulatory complications	0.000	0.998	0.002
I42.8 Other cardiomyopathies	0.002	0.998	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.000	0.998	0.002
T75.1 Drowning and nonfatal submersion	0.000	0.998	0.002
C79.7 Secondary malignant neoplasm of adrenal gland	0.002	0.998	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.002	0.998	0.000
S32.5 Fracture of pubis	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T70 Effects of air pressure and water pressure	0.000	0.998	0.002
E14.7 With multiple complications	0.000	0.998	0.002
E14.0 With coma	0.000	0.998	0.002
H16.8 Other keratitis	0.002	0.998	0.000
I84.7 Unspecified thrombosed haemorrhoids	0.000	0.998	0.002
M23.87 Other internal derangements of knee (Capsular ligament)	0.001	0.998	0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.001	0.998	0.000
R86.7 Abnormal histological findings	0.002	0.998	0.000
X62.9 Unspecified place	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.000	0.998	0.002
H72.2 Other marginal perforations of tympanic membrane	0.000	0.998	0.002
Q89.2 Congenital malformations of other endocrine glands	0.000	0.998	0.002
M23.80 Other internal derangements of knee (Multiple sites)	0.002	0.998	0.000
Q85 Phakomatoses, not elsewhere classified	0.000	0.998	0.002
T81 Complications of procedures, not elsewhere classified	0.000	0.998	0.002
M79.54 Residual foreign body in soft tissue (Hand)	0.002	0.998	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.000	0.998	0.002
C24.1 Ampulla of Vater	0.000	0.998	0.002
Q85.8 Other phakomatoses, not elsewhere classified	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.001
T75.8 Other specified effects of external causes	0.000	0.998	0.001
T75.3 Motion sickness	0.000	0.998	0.001
T75.2 Effects of vibration	0.000	0.998	0.001
T75.0 Effects of lightning	0.000	0.998	0.001
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.001
T75.4 Effects of electric current	0.000	0.998	0.001
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.001	0.998	0.000
H35.8 Other specified retinal disorders	0.000	0.998	0.002
M30.1 Polyarteritis with lung involvement [Churg-Strauss]	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.001
M13.94 Arthritis, unspecified (Hand)	0.000	0.998	0.002
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.000	0.998	0.002
G45.3 Amaurosis fugax	0.000	0.998	0.002
H02.0 Entropion and trichiasis of eyelid	0.000	0.998	0.002
H16.2 Keratoconjunctivitis	0.001	0.998	0.000
Z52.3 Bone marrow donor	0.002	0.998	0.000
H17 Corneal scars and opacities	0.001	0.998	0.000
J94 Other pleural conditions	0.002	0.998	0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.001	0.998	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.002	0.998	0.000
M77.02 Medial epicondylitis (Upper arm)	0.002	0.998	0.000
M43.1 Spondylolisthesis	0.000	0.998	0.001
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.998	0.002
X63.0 Home	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.001
E14.8 With unspecified complications	0.000	0.998	0.001
M31.3 Wegener's granulomatosis	0.002	0.998	0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T67.9 Effects of heat and light, unspecified	0.000	0.998	0.001
T67.8 Other effects of heat and light	0.000	0.998	0.001
T67.7 Heat oedema	0.000	0.998	0.001
T67.6 Heat fatigue, transient	0.000	0.998	0.001
T67.5 Heat exhaustion, unspecified	0.000	0.998	0.001
T67.4 Heat exhaustion due to salt depletion	0.000	0.998	0.001
T67.3 Heat exhaustion, anhydrotic	0.000	0.998	0.001
T67.2 Heat cramp	0.000	0.998	0.001
T67.1 Heat syncope	0.000	0.998	0.001
T67.0 Heatstroke and sunstroke	0.000	0.998	0.001
T69.9 Effect of reduced temperature, unspecified	0.000	0.998	0.001
T69.8 Other specified effects of reduced temperature	0.000	0.998	0.001
T69.1 Chilblains	0.000	0.998	0.001
T69.0 Immersion hand and foot	0.000	0.998	0.001
T73.9 Effect of deprivation, unspecified	0.000	0.998	0.001
T73.8 Other effects of deprivation	0.000	0.998	0.001
T73.3 Exhaustion due to excessive exertion	0.000	0.998	0.001
T73.2 Exhaustion due to exposure	0.000	0.998	0.001
T73.1 Effects of thirst	0.000	0.998	0.001
T73.0 Effects of hunger	0.000	0.998	0.001
T74.9 Maltreatment syndrome, unspecified	0.000	0.998	0.001
T74.8 Other maltreatment syndromes	0.000	0.998	0.001
T74.3 Psychological abuse	0.000	0.998	0.001
T74.2 Sexual abuse	0.000	0.998	0.001
T74.1 Physical abuse	0.000	0.998	0.001
T74.0 Neglect or abandonment	0.000	0.998	0.001
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.001
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.001
M43.19 Spondylolisthesis (Site unspecified)	0.000	0.998	0.001
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.002	0.998	0.000
Q85.9 Phakomatosis, unspecified	0.000	0.998	0.001
T70.9 Effect of air pressure and water pressure, unspecified	0.000	0.998	0.001
T70.8 Other effects of air pressure and water pressure	0.000	0.998	0.001
T70.4 Effects of high-pressure fluids	0.000	0.998	0.001
T70.2 Other and unspecified effects of high altitude	0.000	0.998	0.001
T70.1 Sinus barotrauma	0.000	0.998	0.001
T70.0 Otitic barotrauma	0.000	0.998	0.001
Y40.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
Z98.8 Other specified postsurgical states	0.002	0.998	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.001	0.998	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.001
S32.51 Fracture of pubis (open)	0.001	0.998	0.000
G54.0 Brachial plexus disorders	0.000	0.998	0.001
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.001
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.001
T48.5 Anti-common-cold drugs	0.000	0.998	0.001
Z43.5 Attention to cyctostomy	0.000	0.998	0.001
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.999	0.001
T42.3 Barbiturates	0.000	0.999	0.001
T42.2 Succinimides and oxazolidinediones	0.000	0.999	0.001
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.999	0.001
T48.4 Expectorants	0.000	0.999	0.001
T48.3 Antitussives	0.000	0.999	0.001
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.999	0.001
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.999	0.001
T48.0 Oxytocic drugs	0.000	0.999	0.001
Y40.4 Tetracyclines	0.001	0.999	0.000
Q85.1 Tuberous sclerosis	0.000	0.999	0.001
T42.0 Hydantoin derivatives	0.000	0.999	0.001
T45.5 Anticoagulants	0.000	0.999	0.001
T45.0 Antiallergic and antiemetic drugs	0.000	0.999	0.001
H20.1 Chronic iridocyclitis	0.001	0.999	0.000
L05.9 Pilonidal cyst without abscess	0.001	0.999	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.999	0.001
T70.3 Caisson disease [decompression sickness]	0.000	0.999	0.001
M54.17 Radiculopathy (Lumbosacral region)	0.001	0.999	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.000	0.999	0.001
D48.1 Connective and other soft tissue	0.000	0.999	0.001
J94.9 Pleural condition, unspecified	0.001	0.999	0.000
T41.5 Therapeutic gases	0.000	0.999	0.001
T41.4 Anaesthetic, unspecified	0.000	0.999	0.001
T41.3 Local anaesthetics	0.000	0.999	0.001
T41.2 Other and unspecified general anaesthetics	0.000	0.999	0.001
T41.1 Intravenous anaesthetics	0.000	0.999	0.001
T41.0 Inhaled anaesthetics	0.000	0.999	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.999	0.001
Y40 Systemic antibiotics	0.001	0.999	0.000
D37.0 Lip, oral cavity and pharynx	0.000	0.999	0.001
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.001	0.999	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
Q82.5 Congenital nonneoplastic naevus	0.000	0.999	0.001
T49.9 Topical agent, unspecified	0.000	0.999	0.001
T49.8 Other topical agents	0.000	0.999	0.001
T49.7 Dental drugs, topically applied	0.000	0.999	0.001
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.999	0.001
T49.5 Ophthalmological drugs and preparations	0.000	0.999	0.001
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.999	0.001
T49.3 Emollients, demulcents and protectants	0.000	0.999	0.001
T49.2 Local astringents and local detergents	0.000	0.999	0.001
T49.1 Antipruritics	0.000	0.999	0.001
Y40.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
D63 Anaemia in chronic diseases classified elsewhere	0.000	0.999	0.001
T36 Poisoning by systemic antibiotics	0.000	0.999	0.001
T68 Hypothermia	0.000	0.999	0.001
C49.9 Connective and soft tissue, unspecified	0.000	0.999	0.001
D43.2 Brain, unspecified	0.000	0.999	0.001
H17.1 Other central corneal opacity	0.001	0.999	0.000
H17.0 Adherent leukoma	0.001	0.999	0.000
J94.0 Chylous effusion	0.001	0.999	0.000
T42.4 Benzodiazepines	0.000	0.999	0.001
A46 Erysipelas	0.000	0.999	0.001
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M43.15 Spondylolisthesis (Thoracolumbar region)	0.000	0.999	0.001
M43.14 Spondylolisthesis (Thoracic region)	0.000	0.999	0.001
M43.13 Spondylolisthesis (Cervicothoracic region)	0.000	0.999	0.001
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.000	0.999	0.001
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.999	0.001
E28.2 Polycystic ovarian syndrome	0.001	0.999	0.000
T02.4 Fractures involving multiple regions of both upper limbs	0.000	0.999	0.001
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.999	0.001
T37.5 Antiviral drugs	0.000	0.999	0.001
T37.4 Anthelminthics	0.000	0.999	0.001
T37.3 Other antiprotozoal drugs	0.000	0.999	0.001
T37.1 Antimycobacterial drugs	0.000	0.999	0.001
T37.0 Sulphonamides	0.000	0.999	0.001
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.999	0.001
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.999	0.001
T47.7 Emetics	0.000	0.999	0.001
T47.6 Antidiarrhoeal drugs	0.000	0.999	0.001
T47.5 Digestants	0.000	0.999	0.001
T47.3 Saline and osmotic laxatives	0.000	0.999	0.001
T47.0 Histamine H(2)-receptor antagonists	0.000	0.999	0.001
T66 Unspecified effects of radiation	0.000	0.999	0.001
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.999	0.001
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.001	0.999	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.999	0.001
K09.0 Developmental odontogenic cysts	0.000	0.999	0.001
T20.1 Burn of first degree of head and neck	0.001	0.999	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.999	0.001
T45.8 Other primarily systemic and haematological agents	0.000	0.999	0.001
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.999	0.001
T45.6 Fibrinolysis-affecting drugs	0.000	0.999	0.001
T45.4 Iron and its compounds	0.000	0.999	0.001
T45.3 Enzymes, not elsewhere classified	0.000	0.999	0.001
T47.4 Other laxatives	0.000	0.999	0.001
T47.2 Stimulant laxatives	0.000	0.999	0.001
M43.10 Spondylolisthesis (Multiple sites in spine)	0.000	0.999	0.001
H17.9 Corneal scar and opacity, unspecified	0.001	0.999	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.001	0.999	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.001	0.999	0.000
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.001	0.999	0.000
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.001	0.999	0.000
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.001	0.999	0.000
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.001	0.999	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations